The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

to healthcare professionals to induce them to prescribe the migraine medication Nurtec ODT more often in violation of the anti-kickback statute. The scheme took place from March 1, 2020 ...

Migraine with brainstem aura or MBA (formerly known as basilar migraines) are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness ...

"Patients deserve to know that their doctor is prescribing medications based on their doctor's medical judgment, and not as a result of financial incentives from pharmaceutical companies," said ...

“I often advise patients to have a plan they can enact if they have migraine when they’re away from home,” says Dr. Masters-Israilov. “This includes having effective medications on hand ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Common medications might hold the key to preventing dementia, according to a vast study. Repurposing drugs like antibiotics could offer a swift and economical approach to managing dementia, suggesting ...